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Abstract 
This study invesc~gaLed the efficacy of currenL 
medication treatment procedures for chronic schizophreniss 
on neuropsychological measures . A total of cwenty 
parc:cipants from the Coles County Men~a: Health Center, 
who me~ DSM-:V criteria for chronic schizop~renia , 
volunteered to be admi nistered the Wisconsin Card Sorting 
Test (WCST)-64 card version as a means of assessing 
neuropsychological executive functioning . A total of 
cwenty participants free of any diagnosable psychological 
disorder also volunteered to be administered the WSCT - 64 , 
which served as a control group . The staff psychiatrist at 
tne Coles County Mental Healch CenLer compleced the 
?osicive and Negative Syndrome Scale ( PANSS ) in order co 
deLermine the predomi~ant symptom presentacion of each 
~arLicipant who had been diagnosed with schizophrenia . 
Particip2nt ' s current dosage levels of Lypical and atypical 
medication were recorded and analyzed following che 
completion of tesLi~g . ~esulcs indicaced that cnly one 
index of the WCST-64 could be predicced by medicacion type 
a~d the combi~ed relacionship of symptom presentation and 
medicacion on tne wcs~ - 64 ccu~a noc be compu~ea due co 
small sample size. 
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Chapter I 
Introduction 
Our modern day conceptua lization of the psychological 
construct known as schizophrenia has experienced an 
algorithmic expansion since the coinage of the term in 
1911 . Eugen Bleuler , a Swiss psychiatrist , first proposed 
that schizophrenics posses a dysfunctional dichotomy 
between thought and emotion that is seen exclusively among 
its sufferers . A current taxonomy is offered in the 
Diagnostic and Statistical Manual of Mental Disorders : 
Fourth Addition , and staces that symptoms must be preser.t 
signi:icantly over the cour se of one month , some of which 
must be present for at least a six month period . 
Characteristics of schizophr enia are manifested 
typically as a mi xture of positive (excess or distortion of 
funccioning ) and or negative (diminished or loss of 
functioning) symptomatology which may significantly impair 
social , interpe r sonal , domestic , and occupational pursuits . 
Crow (1980) and Kibei , Laf~ont , & Liddle (1993) state thac 
negative symptoms include poverty o~ chought and speec~ , 
blunted affect , decreased mocor activ~~y , avolicion , as 
we~l as diminished ir.terperso~al interaction (as ciced in 
Be~k, Lucas , & Mactso~ ~997). Kay & Opler (1987 ) scate 
that positive symptoms include delusions , hallucinat ions , 
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and ccncep~ua: disorganization (a s ci~ed in Berk et . al 
1997 ) . Diagnoses of subtype (i . e . pa ranoid , catatonic, and 
diso r ganized) are spe c i fied contingent upon the predomi nant 
sympcom manifes:ation of the sufferer . 
Alchough, as of now , chere appears to be no known cure 
for schizophrer.ia the advent of moder~ medicine has 
provi ded sufferers wi t h new hope fo r i mp roved daily 
functioning . It has been suggested t hat newer medication , 
which have an affinity for dopamine - 2 (02) recepcor blockage 
and act as serotonin a ntagonists , are the most the 
efficacious mechod o f s ymptom manageme nt and treatmen t 
(Alexander (:996) and Stahl (1999)) . Tradicionally , s e l f -
report and observation have been u~ilized to ascercain the 
u~ili ~ y and efficacy of psychcc=opic medica~ion . This 
study atcempced co p r ovide insi;ht in ~ o the ef fec~s of 
medica tion treatment whi le employing a commonly used 
neuro?sychological measure o= execuLive funcLioning . 
Neuropsychological pa radigms and testing materials have 
teen found to differentiate che strengths and weakness of 
suffers of neurologica l deficits and provide a profile of 
cortical :Lnction s (Golden , Golds~ein , & !nc~g~oli ~986 ; . 
Al~~ough neuropsycho~ogical proced~res a~e commonly used 
wichin ~he field ccd2y , they are o:~en cve~:ooked as ~ools 
for ~escing rnedicacion efficacy . 
A ~europsycholog~cal perspec~ive 5 
CHAPTER I= 
Rev~ew of Literature 
Researchers over the past several decades have worked 
diligently to uncove r conclusive empirical evidence 
regarding biological or environmenLal substrates 
conLribuLing co the etiol~gy and progression of th~s 
crippling disorder . The research in the area cf 
schizoptrenia and information processing has been focused 
on identi:ying c~gni~~ve deficits which may provide us wi:h 
deeper ~nsighL into this psychological construct (Green 
1996) . CogniLive defi cits found among schizophrenics 
appe ar to be varied due to of the heterogeneity betwe en , as 
well as with~n, each subgroup . However , schizophrenics 
collectively perform poorly on v~rLually a~~ measures c: 
cognitive abi:ity (Green 1996) . There appear to be two 
distinct types of cogn itive deficits underlying this 
disorder : those that arc ccncra~ to ~he d~sorder and cnose 
that emerge as a resul~ of psycho:ic episodes or Lhe 
effects of psychoLropic medicaLicr.s {Green 1996) . 
Dif:eren~iation of Lhese two forms of deficits in cognitive 
funcL~On~ng may be test ur.derscood when lcngit~dinal 
scud~es are employed chat del~neate de~~c~cs 9~~senL 
exclcsive:y curing psyc~ocic episodes from those thaL are 
stable Lhroughouc the course of the i:~ness . The latter 
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may serve as "cognitiv~ markersn for subsequent psychoLiC 
episodes (Van Der Does eL . al 1993) . A wide rarige of 
information processing deficics may be found during 
prodromal and residual stages . 
Van Der Does et . al (1993 ) looked at groups of chronic 
schizophrenics and compared measures of information 
processing to groups of depressed participants wit~out 
schizophrenia and control participants (those free of 
clinical diagnosis) . They found chat differences occurred 
between groups with regards to the type of information 
processing skills which contributed to problem- solving 
ability . Specifically , it was found that the schizoph=enic 
group showed significant impairment in molecular 
information processi~g (i . e . reaction time , reaction time 
release , backwcrd masking , and vigilance) . Ic was 
concluded from this s~udy that , " social cognitive problem 
solving is associated with sustai~ed attencion among 
individuals with a mood disorder and with a liberal 
response style among indi7iduals with schizophreniau 
19) . 
In general , findings in che area of ci ~nical 
neuropsychology have lead to tne propositian that 
(
" !:' . 
schizophrenia is associac2d with subcor~ica: dysfunction , 
la~er~lized dysfu~cLion , le:t hemisphere cie:ici~ and 
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overactivation , impaired interhemispheric integraticn , and 
frontal dysfunction (Craft , Levin , & Yurgelun 1989) . The 
use of neuropsychological testing paradigms have been 
instrumental fer researchers examining these areas of 
d e ficit among schizophrenics . 
Neuropsychological deficits are impairments in brain 
functioning that may inhibit behavior and various degrees 
of psychological functioning . Measures designed to assess 
these impairments attempt to address behavior deficits and 
allow admi nistrators to make inferences regarding 
dysfunct i on in corresponding cort i ca l and subcortical 
regions of the brain . Psychological i mpairments related to 
brain dysfunct i on are typically measured by using 
standardized tesLing procedures . Neuropsychological 
assessme nt procedures a r e an extension and quantification 
of part of the neurologic examination concerned with higher 
cortical functioning (Golden , Goldstein , & Incagnoli l986 ) . 
The benefit of neuropsychological assessment over some 
classical medical neurologica~ procedures is that they 
appear to be more sensitive to cognitive and personality 
changes . These forms of tesLing batteries different~~Le 
che strengths and weaknesses of sufferers of 
neuropsyc~ological de£~cits a nd orc vide a profile 
cortical f unc~ions (Golden et. al 1986 ) . 
It has been suggested tha~ chroni~ schizophrenics show 
significant cognitive de:~cits , which are evident in 
performance on cognitive- based tests . A study conducted by 
Bcronow , Dickerson , & Ringel (1991) investigated the 
relationship between neuropsycholosical deficits among 
chronic schizophrenics regarding symptom manifestation and 
found that the deficits that were found co be correlated 
with predominant symptom manifestation were memory and 
intellectual processes . 
Impairment in voluntary and involuntary motor contro: 
are o:ten observed in chronic schizo9hrenic patients ( Cr==~ 
et . a~ 1989 ) . Neuropsycho~ogical measures that assess 
motor ability in schizophrenics routinely find a range o: 
impairments from motor deficits of simple tasks , such as 
finger tapping and manual dexterity , to complex percept~o-
motor tasks , such as reaction time (Craft et . al 1989) . 
Crc~tcr visuomotor deficits have been found in 
schizophrenics with primarily r.egative s;rnptoms than i~ 
schizophrenics with primari~y positive sym~toms (:raft st . 
a: ::..989 } . ~nc.erpretaticn o: tr.ese :ir.aings s~gges~s 
fronta~ l obe impairment found in sch~=ophrenics wi:h 
predominant: nega':ive symptoms may· disrupt: c.nei..c aoili;:.\.: ~'.) 
organize visuoconstructional tas~s <cra!L e~ . al 1989) . 
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fraustman et. al (1988) and Lawson et . al (1988) 
found no significant relationship between predominant 
symptoms manifestation and neuropsychological deficits ir. 
chronic schizophrenics , however these findings may be 
difficult to interpret because the participants were 
unmedicated at the time of testing (as ci~ed in Boronow e~ . 
al 1991) . Both studies found that memory ar.d intellectual 
processes were impaired among chronic schizophrenics 
regardless of predominant symptom manifestation . 
Several neuropsychologically based studies with 
chronic schizophrenics have focused on observations of 
abnormal speech processes . Abnormal speech patterns of 
schizophrenics strong ly resembles Wern~cke's aphasia, which 
may suggest brain dysfunction of the left temporal lobe 
(Cra ft et . al 1989) . However , no significant impairment of 
elementary language functions , i . e . naming and repetition 
has been found . 
Memory dysfunction found in schizophrenics suggests 
neuropathological changes in medial l imbic struc~ures of 
the temporal lobe includin~ the hippocampcs , era£~ et . al 
1989) . It has been suggested by Luria ( l966 i , t~at loss of 
higher cor~ical functions in patients ~it~ a lccalized 
brain injury leads to significant cha~ges ~r. ~~e p~ocess of 
learning , affecting the quali~y and char3cte~ of the 
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results cbtained in relation LO memcry processes (as cited 
in Berg et . al 1982) . The study of memory processes with 
schizophrenics has largely focused on ascertaining whether 
or not distinctions exist between encoding and retrieval 
processes, verbal and visual memory, and free recall and 
recognition memory . The functional consequences of memory 
impairment may foster a diminished capacity for appropriate 
social skill acquisition , problem solving , and overall 
information processing . 
Actention deficits in schizophrenia are chought to be 
both a clinical symptom and underlying mechanism of other 
cognitive dysfunctions (Craft et . al 1989) . One theory of 
attention deficit in schizophrenia is that sufferers are 
incapable of selectively attending to certain stimuli . 
Another theory staces that the slowing of neurocognitive 
functioning in schizophrenia correlates with attentional 
deficits (Craft et . al 1989) . It is imperative chat , due to 
the complex naLure of the various aspects of attention, 
researchers o perationally define this conscr~ct in their 
scudies . 
Pref r ontal lobe dysfunction in schizophr~nia has long 
been recognized . However, variabilicy sxis~s among 
sufferers in thac not all exhibi t dysfunccicn to che same 
degree . Walsh ( 1985) states Lhat cognicive defic~ts 
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mediated by pref rontal lobe funcLioning are L~ose th2t 
allow an individual , " LO respond and adapt appropriately tc 
his or her environment " (as cited in CrafL et al , 1989 , µ . 
345) . These cognitive processes collective ly designa Le 
whaL are commonly referred to as executive functioning and 
are ofLen found to be impoverished among schizophrenics . 
Although e xecutive functions are widely be lieved to be 
mediated by the pre: r ontal lobes , it is poss ible that other 
corcical and subcorLical bra~n SLructures conL=ibuLe LO 
these processes . Fo r this reason , che use of the te rm 
executive appea=s to be more accurate than what was 
corrunonly r e f erred to as prefrontal functioning . 
Seve ra l studies t h a t have i mp lemented 
neuropsychological tescing procedu r es with s chizophren i cs 
have found impairmen~ in frontal lobe funcLio~ing . Ko ~ o 
and Whishaw (1983) f ound that measures of r i ght - and lefL 
f~ontal and temporal functions suggested signi=ica~~ly more 
impairment i n schizop h r enics than controis (as cited i n 
Cra:t et . al 1989) . 
I: is suggested in gene=a~ . rega~dless o: i~L=l~~?e~ce 
:~vel , that schizophr enics perform poorly on the Wisconsin 
CarL Sorting Test (WCST) . The WCST has been suggested co 
place h~gh demands on func:ions o~ che pre~roncal co=~ex , 
dS well as i~s coordina Lion with che ~imbis svstern rncs~:y 
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regarding the amygdala and the hippocampus (Harvard Mental 
Health Letter , 1999) . Most notably found in performances 
among schizophrenics are signs of perseveration , which is 
believed to be an , "inability to change expec~ations and 
adopt to new information" (Harvard Mental Health Letter , 
1999) . Certain negative symptomatic behavior of 
schizophrenia manifested as blunted affect , emoLional 
withdrawal , lack of spontaneity , and loss of drive parallel 
Lhe apathetic syndrome of the prefrontal lobe (Berk et al . 
1997) . Pref rontal dysfuncLion has been found to be more 
strongly correlated with negative symptom manifestation 
than with positive symptom manifestation . Specifically, 
schizophrenics with predominantly negative symptom 
manifestations presented deficiencies in the iniLiation , 
planning, and organization of material , difficulties in 
shifting cognitive set , recent memory impairment , and 
slowed rate of learning and on slowing of thought (Berk et 
al 1997) . They suggest that , in regards to anatomical 
SLructures, such dif:iculties correlate with deficits of 
the dorso-lateral and medial prefrontal areas . 
Results from st~dies using magnetic resonance i~agir.g 
(MRI) indicate structural anomalies of the prefrJnLal 
cortex in schizophrenics (Berk eL al . 1997) . Br3in scans 
taken while testing schizophrenics on behaviors media~ed by 
t:he prefrontal corLex, i~aica:e c~ac correspcnd~n~ 
structures are unable to meet requirements of the task and 
that blood flow appears to be lower Lhan normal in t:his 
region (Harvard Mental Health Letter , ~999 ) . 
Alchough at the curre~: cime t~ere appears t:o be no 
k~own cure for the pervasive cognicively- degeneraLive 
disorder referred to as schizophrenia , new methods of 
symptom management and r elapse prevention have caught the 
attention of many researchers and health care professionals 
during the end of che LWentiet~ century . It is imperacive 
that treatment surrounding the schizophrenic population 
must consider the heterogeneity among its suffers . Kane 
and McGlashan (1995) state that the most pragmatic 
therapeutic approach in effectively treating chronically 
disabled persons is by , "integrating drug and psychosocial 
treat:ments" (p . 820) . 
Deficits in social functioning are commonly exhibited 
in schizophrenics and appear co be pervasive throughou~ the 
various scages of illness . Methods of remediation are 
frequently employed to improve c~e i~poverished levels cf 
psychosocial functioning of the schizophrenic sufferer . 
Specialized programs have been designed ~0 train 
s=hizopnreni=s on a ranee o~ speci~ic sk~::s , " inc:~d~~g 
basic convecsacion , interperso~al problem solving , and 
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medication managemenc " (Corrigan , Green , Sc~ade , & Wallace 
1994} . Psychosocial treatment programs are typically 
designed so that skilled professionals develop an 
environment that is conducive to social skill enhancement 
by facilitating role plays regarding target behaviors , 
offering constructive feedback for client participation , 
and by offering reinforcement for successive approximations 
of a target behavior (Corrigan et . al 1994) . Corrigan et . 
al (1994) state that research in the area of treatment for 
psychosocial deficits in schizophr enics have found that 
many participants , " improve their repertoire of 
interpersonal and coping behaviors " (p . 6) . 
The majority of outpatient psychosocial rehabilitation 
services available for sufferers of schizophrenia address 
improving interpersonal skills , community integration and 
provide vocational training opportunities . Ofcen times 
structured and mon i cored housing is integrated into a 
patient ' s comprehensive treatment plan . One major 
advantage of the use of specialized psychosccial 
rehabilicacion programs is , "avoiding inscicutionali=acion 
with its learned dependence and tru~cating che l o ss of 
healthy mental capacity and ccping skills (Kane & McGlasha~ 
1995 ) •II 
A ne~ropsychological 
The advancement of modern psychoLropic medication has 
provided researchers with a richer conceptual:zat~on of 
t his mind crippling psychiatric disorder as wel l as 
offering promise for the prognosis of i~s suff2rers . The 
advent of antipsychot i c medication has contributed to a 
greater understanding of the aetiology , as well as the 
pathophysiology of schizophrenia (Kane & McGlashan 1995) 
The spotlight on pharmaceutical agents f or the treatment o: 
major psychoses has shifted from traditional or " typical " 
medications such as haloperidol and chlorpromazine to the 
progressive " atypical " agents such as clozap:ne and 
risperidone . It is suggested that the new atypical 
pharmaceuticals , offer efficacy in positive symptoms 
(hallucinations , delusions , suspiciousness and persecution , 
agitation , and conceptual disorganization ) and in negative 
symptoms (flat affect , emotional withdrawal , apathy , 
anhedon i a , and alogia) (Alexander 1996) . Of most 
importance is that the newly discovered atypicals provide 
efficacy for negative symptom manifestation , whi ch is ~OL 
found in older cypical agents . 
Typical medications , otherwise known as 
" conventional " , vary in poLency and d egree of side-effecL 
inducement ; however , iL is believed that all are effective 
in reducing psychocic symptoms , specifically positive 
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symptoms due to thei r af:inity fo r dopamine - 2 (02) recepcors 
(Stahl 1999) . It appears that typical medication provides 
efficacy in controlling posicive symptoms of schizo9hrenia 
by acting a s an antagonist in syn aptic sites of the 
mesolimbic dopamine p a thway , wh i ch projects from the 
ventral tegmental a=ea through t he medial forebr~i~ bundle 
to the amygdala , the lateral septum, the b e d nucleus of the 
stria termina~is , the hippocampus, and the nucleus 
accumbens (Carlson 1995) . Stahl (1999) sta~ed tha: , 
" b lockage of postsynaptic dopamine r ecep to rs in the 
mesolimbi c pathway is thought to mediate the antipsycho:ic 
efficacy of the antipsychotic drugs , and t~eir ability to 
diminish or block po s i t ive psychotic symptoms u (p . 38) . 
Unfortunat e ly , typical or conventional medication may also 
produce undesirable s : de- ef fect s such as extrapyramida l 
symptcms (EPS) and tardive dyskinesia , wh i ch are a product 
of the 02 blocking properties of these medications . 
Extrapyramidal symptoms are produced by blockage of 
receptors i n the nigr ostria:al dopamine pathway (which 
project from che substantia nigra and termi~ate :r. :he 
basal ganglia) . The ~igros:r:acal dopamine pathway is part 
of the extrapyramidal neurona: system of the centr~l 
nervous system, and olockage o= associaced dcpamine 
receptors produces disorder of movement referred to as 
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extrapyramidal symptoms (Stahl 1999) . When dopamine 
receptors in the nigrostriatal pathway are blocked for a 
significant length of t i me , the irreversible hyperkinetic 
disorder known as tardive dyskinesia may be a result . 
Interestingly, typical medication may also produce 
side- effects that resemble the negative symptoms of 
schizophrenia . Such side- effects occur when typical 
medication blocks dopami~e receptors in the mesocortical 
pathway (which begins in the ventral tegmental area and 
terminates in areas of the frontal and pref rontal lobes , as 
well as in the limbic cortex , and hippocampus (Carlson 
1995) . 
It is believed that the more recently developed 
atypical medications differ from that of traditional 
typical medicacion on three levels of e f ficacy . Stahl 
(1999) states that atypical medication differs from typical 
medication producing little or no cxtrapyramidal symptoms 
or tardive dyskinesia , by not raising prolactin levels 
like traditional typical medications , and by having greacer 
efficacy for controlling negative symptoms over typical 
medication . 
Oi most relevance to cne currenc SLudy is tne efficacy 
of the progressive acypical med~sation on controlling the 
deficiency er receptors in the mesoccrtical dopamine 
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pachway , wh~ch mediates negative symptom ma~ifestation . 
is believed that the ef~icacy of atypical medication in 
... 
... -
controlling negative symptom manifestation is due to their 
pro9erties of being both a serotonin and dopamine 
antagonis:. . Stahl ( 1999 ) staces tha:. another hypothetical 
cause of the negative symptoms of schizophrenia, other than 
primary deficiency of dopamine in the mesocortical pathway , 
is that of secondary deficiency of "dopamine in the 
mesocortical pathway as a result of serotonin excess" (p . 
57) . It is believed that serotonin opposes or inhibits the 
release of dopamine and tha~ agents with antagonistic 
serotonin propensity wil l consequently produce an increase 
of do9amine by disinhibition . The e =: icacy of a~ypical 
over typical med~catior. in treating the negati·1e symptoms 
of schizophrenia is the result of the seroton~n-dopamine 
antagonistic properties which have the capacity to increase 
dopamine release selectivity in the rnesocortical pathway 
(St:ahl :.999 ) . 
The current study atcempted to provide fu=cher insight 
in:.c the efficacy of medication trea~ment for chronic 
schizophrenia . Of particular interest, was the influence 
cf the r.ewly discov3~ed atypica: ~edica:.ions e ver the 
traditional typical medicacion ori exec~~ive : unctioninq 
:or schizo~hr~nics ~ha~ express predomi~ar.:. l y more negative 
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symptom manifestations . It is hypothesized in general , 
based on previous empirical support (Berk Lucas , & Mattson 
1997) , that those who possess predominantly more negative 
symptom manifestations will perform significantly worse on 
measures of executive functioning than those that posses 
predominantly positive symptom manifestations regardless of 
medication type . Specifically , it is hypothesized that 
~hose participants who posses predominantly more negative 
symptom manifestations , and whose treatment involves higher 
levels of typical medication , will perform significantly 
worse on measures of executive functioning when compared 
to participants with similar predominant negative symptom 
manifestations whose treatment involves higher levels of 
atypical medications . The latcer hypothesis is based on 
empirical support (Stahl 1999) suggesting the efficacy of 
atypical medication on negative symptom man~festation . It 
has been suggested that atypical medicution shows greater 
efficacy for negative symptom manifestations par~ly by 
dddressing deiiciencias in che meso-ccr~ical dopami~e 
pathways which have termination si~es in :he frontal and 
prefrontal cor~ex . Also suggested is that such 
deficiencies may result in impoverished executive 
function~ng, thus it may be hypothes~zed tha~ increased 
levels of dopamine in ~he prefr~n~al cor~ex (~esult~r.g f~om 
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atypical medica~ion use) could influence measur~s of 
~xecutive functioning . The current study differs ~rom 
orevious studies by employing a neuropsychological measure 
of executive functioning in attempts to delineate 
predominant symptom manifestation and medication ~reatment . 
It is hoped that the contribution of this study may lead to 
subsequent research on medication efficacy regarding the 
use of neuropsychological testing paradigms and to add 
empirical support to the ever- developing conceptualization 
of this psychological construct . 
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CHAPTER II 
Method 
Participants 
Par~icipants were drawn from the Coles County Mental 
Health Center and were members of a specialized community 
mental health rehabilitation program . All participants 
used in the sample met DSM- IV criteria for schizophrenia , 
regard~ess of subtype ( Undifferentiated N= 7 , Paranoid N= 
7 , Schizoaffective N= 5 , Residual N= 0 , and 1 
undetermined) . A total of 20 participants diagnosed with 
schizophrenia who ranged in age from 30- 66 years old(~ = 
48 . 55 , SD = 9 . 24) and with 8 to 13 years of education 
volunteered =or this study . 
A cor.Lrol group of participants from the community 
free of any diagnosable psychological disorder volunteered 
for this study in order to strengthen the validity of the 
testing procedures . A total of 20 control participants 
were selec~ed whose ages ranged from 18 - 57 years old (M = 
27 . 60 , SD = 10.09) ~ith 11 to 17 years of education . 
Materials 
The c~rrent study used the Wisconsin Card Sorting 
Test - 64 Card Version (WCST-64) to measure executive 
functioning . Currently there are no studies that de~ermine 
the validicv of Lhe WCST-64 . However Heaton, Iverson, 
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Kon~s , and Thompson (2000 ) state that since this version 
and previous versions have the same task requirements and 
is derived from the same sample population , much of what 
has been found from the earlier versions will generalize to 
the current version . The new WCST ( 64 card version) was 
chosen over older versions due to its shorter 
administration time , which was considered to be beneficial 
due to deficits o: attention span often found among 
schizophrenics ( Cra:~ et . al 1989, and Carpenter , Gold, 
Goldberg, Randolph, & Weinberger 1992 } . 
The WCST-64 is a widely used test of executive 
functioning in which participants are given a pack of 64 
cards which cor.tain as few as one and as mar.y as four 
different syrneols : triangle, star , cross, or circle in 
eithe r red , green , yellow , or blue . There are no cards 
that are identical regarding shape o r color . Lezak (1983) 
states that this task requires the participant to , "place 
[cards] one by cne u~der four sti~ulus cards -- one red 
triangle, two gr~en s~ars , three yellow crosses, and four 
blue circles-acccrd:.ng co a principle that the patient must 
deduce from the pa~:erP- if the examiner ' s response to the 
pa-i:.2..ent' s p l acemen'.:. o: ;:ne -:ards" (9 . ~8 8) . 
basis fer sor~~ ng :s i~ regaras co co~or, cher. f:rm, 
number , back t o color , and so on . Participants are g~ven 
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feedback af~er each trial informing them whecher or not 
Lheir response was correct and principles for matching are 
changed after 10 correct responses . The test is terminaLed 
when the participant attempts 64 trials or achieves six 
correct categories . Scores generated by the WCST - 64 for 
clinical pur9oses include : perseverative errors ( PE) , which 
represent the number of errors in which a parcicipant 
responds incorrectly while using the same response pattern; 
nonperseverative errors (NE) , which represent the number of 
responses that are incorrect which do not met criteria as 
perseveracive errors ; total number of errors (TE) , which 
represents the sum of perseverative and nonperseverative 
errors ; categories completed (CC) , i n wh i ch i s scored by 
t~e number cf times a participant scores 10 consecutive 
items ; failure to maintain set ( fM ) , which represents a 
partic i pants inability to complete a category a:ter 
successfully completing at lease 5 crials within the same 
sorcing principle ; and conceptual level (CL) , which 
represents consecut~ve ~2sponses that are " correct in 
groups of ~hree or mor: divided by the tocal number of 
responsesu ( Bell et . al 1995 ) . It is suggested that a poor 
oerformance on the WCST indicates difficulty in sorting 
regarding catego rical ins~rucc ions, whi2h may be indicati7e 
o f a n impaired abilicy to form concepts . Pa=~icipan~s with 
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particula~ly left frontal lobe damage involving the medial 
area often exhibit such diminished capacity (Lezak 1983) . 
I~ general , the WCST - 64 assesses the executive or " frontal " 
functioning of planning , organization , cognitive 
flexibility in shifting set , working memory , and inhibition 
of impulsive responding (HeaLon et al . 2000) . It has been 
found Lhat the perseverative response score has achieved, 
"the best diagnostic accuracy, correctly classifying 74% cf 
the total impaired group and 72% of the normals " in the 
initial normat i ve sample (Mitchell , 1985 , p . 1746) . In 
general , it is believed tnac the WCST - 64 is mosc accurace 
in differentiating between pat ients with focal frontal 
lesions and has long bee~ found to be beneficial in 
diagnosing neurological problems (Mitchell 1985) . 
The ?ositive and Negative Syndrome Scale (PANSS) was 
used as an indicator of predominant symptom manifescation 
among participants . The 2ANSS consists of 29 items which 
determi~es the presence of positive (items 1 , 4 , 5 , 6 , 17 , 22, 
and 23) , negacive (items 7,8 , 3, 10 , 11 , l5 , and 16) and 
general sympccms (i cems 2,3 , 12 , 13 , 14 , 18 , l9 , 20 , 21 , 
24 , 25,26,27 , 28 , ana 29) 0f the par~icipan:'s disorder . 
Scc~es are ob-ca ined by, "si..:mming the sc8res of individual 
items composin~ each com~onenc [positive, negaLive , 
cognitive, hos=ility , and emc~ional discomfort] {Bell et . 
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al 1995) • II Examples of positive symptoms reported on the 
PANSS include "delusions " and " hallucinations " . Negative 
symptom examples include the presence of "passive withdraw" 
and " blun~ed af ~ect ", and general symptom examples include 
"preoccupation" and "motor retardation". Predominant 
symptom manifestation will thus be evident by considering 
the number of co .:-responding symptoms in each component . 
Procedure 
All participants were admi~istered the Wisconsi~ Card 
Sorting Task (WCST - 64) when they were clinically stable on 
neuroleptic medication and cooperative and compliant to 
testing instrucLions to assess levels of executive 
funcLioning . The testing environment consisted of a 
private room within the psychosocia: rehab~litation 
facilities . Each participant received a two dollar 
monetary incentive(non-contingenc upon Lheir completion of 
the WCST-64) for their volunteering to participate in this 
study . Personal demographic information regarding 
mec~cation, cu=~ent age , education ar.d diagnosis was 
obta~!!ed upon perm~ssion gran~ed from each par~icipant . 
The Positive 3nd Negat~ve Syndrome Scale ' PANSS ) was 
completed by the staff psychia~r~s~ and was returned to 
st:udy' ~ ori.:nar."; 
- -
fo.:.i.;Jwing testing in 
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ordec to r~auce the confounding effect of ~esearcher 
confirmati~n biases . 
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Chapter I:I 
Resuli:s 
Results of the PANSS indicated that the range of 
positive and negative symptom p reseni:ation va=ied from 0 to 
6 items reported and 1 to 6 iLems reported under the 
general symptom index . All pari:icipants were identified as 
having some symptom presentation related to their disorder 
with in the last 6 months . rn:ormation regardin; 
medication treatment indicated that the range of typical 
dosage varied from 0 mg to 150 mg (~ = 25 . 97 , SD = 48 . 81) , 
and atypical medication dosage varied from 0 mg to 160 mg 
(M == 17 . 56 , SO== 34 . 38) . 
All participants in the experimental group revealed 
some level of impairment in e;<ecuti ve functionir:g as 
evidenced by results obtained by the WCST-64 . Only 3 
participants successfully completed 3 cai:egories . Of these 
scores , all 3 par~icipar.t ' s scored a percentile ~3nk of 
>16 . Table 1 shows the scores of the par~icipar:~s in the 
experimencal group on each ir:dex of the WCST - 64 as divided 
ini:o qualifiers ra~gi~g from severe impair~eni: c~ a?e=age 
(no impairment ) 
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Table 1 
Number of participants in the expe~imental group who scored 
in each qualifier of the WCST-64 . 
Qualifiers 
Index severe moderate mild/~oderate mild *below average *average 
TE (N=l) (N=5 ) (N=7) (N= O) (N= 3) 
PR (N=l) (N=O) (N=4) (N = 4) (N = S) 
PE (N=2) (N=l) (N=7) (N= 2) (N= S) 
NE (N=l ) (N= O) (N= 9) (N=6) (N=2 ) 
CL (N=3) (N=3) (N=6) {N=S) (N=2) 
Note. TE: = Total Errors, PR = Perseverative Respcnse , PE = Perseverati'1e 
Errors , NE= Nonperseveracive Errors, and CL = ConcepLual Level 
*below average and average index represent3 no :mpairmen:. 
(N=4) 
(N= 6) 
(N=3) 
(N= 2 ) 
(N=l) 
Only one member of the control group exhibited any 
level of impairment with executive functioning as evidenced 
on the WCST-64 . All but one participant completed 3 er 
more categories and scored a learning to lear~ percentile 
score >16 . Table 2 shows the scores of che contro~ ~~oup 
on each index of ~he WCST - 64 as divided in~o :he same 
qualifiers as ~r.e exper~men~a: ~rcu7. 
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Table 2 
Number of participants in the control group who scored i~ 
each qualifier of the WCST-64 . 
Qu2lif ie.::-s 
Index severe mild / moderace mi:d *below a7erage *average *above av~. 
TE (N= l) (N=O) (N= O) (N=O) 01 =7 ) (N=6) 
PR (N=O) (N= O) (N=O) (N=l) (N=l3) (N= 6) 
PE (N= O) (N=O) (N=O) ( N= l ) {N=6) (N=:.3} 
NE (N=l} (N= O) (N= O} {N=l) ( N= l :!. ) ( N= 7) 
CL ( N=l) (N=O) (N=O) ( N=l) (N=l5 ) (N=3 ) 
Note . TE = Total Errors, PR = Perseverative Response, PE "" P-:rseverative 
Errors , NE= Nonperseverative Errors, and CL = Conceptua: Lavel 
*below average , average, & above average index represen:s no ~mpa:r~ent . 
Results of 2 Pearson Correlation revealed that there 
was a significant relationship between medication type and 
perf0rmance on the Failure to Maintain Set index of the 
WCST - 64 . Those participants with lowe~ levels of atypical 
medlcation were less able to mainLain set thar- those with 
highe~ levels of atypical medication . Res11l cs are 
re9resented in Table 3 . 
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Tab:e 3 . 
Results of a Pearson Correlation for medication ~ype and 
performance on the WSCT - 64 . 
M d . .. . 'T' e icaLior: _ype 
Index Typical Atypical 
cc -. 111 - . :;_93 
f M -. 265 . 493* 
TE -. 180 -. 117 
PE -. 022 - . 266 
2R -. 166 . 257 
NE . 225 . 329 
CL -. 222 -. 052 
TC -. 095 -. 208 
TF -. 227 . 143 
Note. TE = Total Errors, PR = Perseverac.:.ve !<.esponse , PE = 
?erseverat.:.ve Srrors , NE = Nonperseverative Srrors, a~d CL = Conceptual 
Level , CC = Categories Completed , E"M = E"a2.lure co i\/!ai.'.'.t:ain S~t, 'I'C: = 
To~a: Number Correc~ , and TF = Tria:s to Complete firs~ Trial. 
*significan~ at p < . 05 . 
Resu~ts of a Pearson Correlation revealed ~~at there 
wer~ no significant rela~ionships betNeen predcmi~ant 
symptom presentation and performance on ~~E WCST-64 . 
Results are represented in table 4 . 
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Table 4 
Resulcs of a Pearson Corre2aticn for symptom pres2ncacion 
and performance on the WCST-64 . 
Sym~Lvrn ? .::-'=sem:a i: ior. 
Index ?ositive Nega:.:.ve General 
cc - . 1 76 -. 316 - . 375 
f M . 101 - . 273 . 238 
TE -. 118 . 002 . 017 
PR - . 137 -. 265 - . 22l 
PE - . 145 -. 248 - . 158 
NE . 069 -. 176 - . 047 
CL - . 134 - . 365 - . 266 
TC . 073 - . 404 - . 065 
Tf -. 216 - . 196 . 076 
Note . TE = Total Errors , PR = Perseverar.ive Response, PE = 
Perseverat~ve Errors , NE = Nonperseverative Errors , and C~ = Cor.ceptual 
Leve~ , CC = Categories Completed , FM = Failure to Mair.tain Se~, TC = 
Total Nwnber Correct , and TF = Trials to Comple:e First Trial. 
Signif:_cant di:ferences were foGnd en all WCST - 64 
between :he con~=o! group and the e~per:.mencal group . 
Results of a t-cest for independen~ means are rep~esen~2d 
i.!l L.able 5. 
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Table 5 
Cescriptive statistics for the experimencal and control 
group/s perfor~ar-ce on each index o: the WCST-64 . 
Exoeriment:a.'.. Grcuo Ccntrol Group 
:nde:< SD M SD M 'i' Sec re 
TE 13 . 09 10 . 45 23 . 75 67 . 40 -9 . 38.,. 
PR 16 . 69 19 . 30 24 . 83 58 . 20 - 5 . 81* 
PE 17 . 55 18 . 15 24 . 83 67 . 50 - 7 . 25-.c 
NE 23 . 22 16 . 45 25 . 08 51. 20 - 4 . 54* 
c:., 9 . 61 7 . 15 22 . 54 49 . 95 - 7 . 80* 
cc 5 . 67 7 . 30 1. 78 15 . 60 - 6 . 23* 
FM . 76 . 80 . 41 . 20 3 . 08 *.,.. 
TC 11. 35 31. 20 7 . 28 52 . 40 - 7 . 02 " 
TF 6 . 62 9 . 75 . 97 15 . 30 -3 . 70* 
Noce. TE = Total Errors , PR = Perseverative Response , PE = 
Perseverative Errors, NE = Nonpersevera=ive Errors , and CL = C0ncep~ual 
Leve:, :c = Categor~es Com~let~d, c~ = :ai:ure co ~a~~cai~ Se~, TC = 
Toed_ Number Correc~, and TF = ~r~als to Complete f~rs~ Trial . 
*S.!.gn~f.:.cant a;: p <. • 001 , • •Signi::..cant: at p < . 005 . 
A ParLial CorrelaLion co~ld not be conduc~ed to 
deLermine che combi~ed re:a~ionship of sympLom prese:.~a L~~r. 
and performance on the WCST-64 due to the insignif icanL 
r~sul;:s found with 1:he Pearson Correiation betweer:. svmoi:)m 
p~esentat~Jn and per:or~ance on che WCST-64 . 
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A Linear Regression co determine possible main ef feCLS 
and interactions of medic ation ~ype could ~ot be conducLed 
due to the small sample size of this study . 
Chapt~r IV 
Discussion 
Results from chis study indicated that the WCST - 64 
successfully de!ineated tetween c~e experime~:al and c~e 
concrol group , however the ef:icacy o= medicat~on ~reacme~c 
for chronic schizophrenia could not be ascertained . A 
signi f icant correlaticn between medicat i on treatment and 
perf o~mance or: ~he WCST- 64 was found only between the 
fai : ur e to Maintain Sec index and acypical medica~ion . 
This index measures participancs 
i nab i l i ty to complece a category afte r completing 5 
successful trials . One ' s failure to maintain set 
represents an inability to sore cards s~ccessfully ~hrough 
changing stimuli a:te r escabiishing the cor=ect matching 
principle (Heaton et . al 2000) . S kills required in 
successfully maintaining sec may encompass many of the 
defining features o: execut~ve funccion~ng . Mose per~ine~t 
is a der~n~~ion by Craft ec . al (1989 , p . 345 ) , which 
descr ~bes executive functioning as che ''abilicy co get into 
the appropriate response set for a given task , mainta~n 
chac se~ , and to snift as needed . n T~e res~lts of chis 
st~ay suggest :na~ a:ypical medica:~cn may be ~f~icacio~s 
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on improvi~g t~is abiii:y among sch~z~phre~ics and suppor~s 
inicial hypot~eses of this SLudy . 
Overall , limiced findings of this study may be 
explained by first , the levels of cognitive impa~rment 
among the experimental group may have been too severe to 
delineate any within group variability . Second , in orde r 
to thoroughly address executive fJnc=ioning , a more 
comprehensive neuropsychological bactery should be 
considered . Finally , the small sample size of this study 
may have masked some pocentially significant results . The 
relationship o f symptom presentation and medication 
treatment on performance on the WCST - 64 could r.ot be 
computed , along with possible main effeccs and inceractions 
of med~cation cype , as a result this limi~ed sample size 
and insignificanc findings of a Pearson Correlacion . 
As was expected , the WCST - 64 effectively delineated 
cognitive impairment between the experimentaJ and control 
group . This finding strengchens prev~cus assumptions 
regardi~g its e::~cacy of distinguishing becween 
cogr.i~ively impaired par~icipan~s . Per:ormar.ce on a:most 
311 of :he icerns on cr.e ~SCT-64 were f ound co be 
significancly worse for the experimenca: g=oup than with 
t~e contro: group . 
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Future studies of this nature may show more valid and 
generalizable results by an increased sample size . 
Increasing the number of neuropsycho l ogical teSLS used may 
also provide a richer profile of executive f~ncLioning and 
potentially present a greater variaLion of cognitive 
impairment among schizophrenic participants . Since a 
baseline of cognitive functioning prior LO tte introduction 
of medication trea tment for each participant in the 
experimental group was not established, assumptions which 
minimizes the benefits of atypical medication over typical 
medication may be erroneous . Future researchers may 
consider establishing baselines of cognitive functioning 
and designing longitudinal studies which may lead to more 
conclusive findings . 
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